Nothing to see here.
" The best vaccine is the one that you are offered".
News, analysis and comment from the Financial Times, the worldʼs leading global business publication
Denmark became the first country to drop the Johnson & Johnson Covid-19 shot from its vaccination programme owing to blood clot concerns, weeks after also excluding the Oxford/AstraZeneca jab. The Danish health authority said on Monday it had concluded that the benefits of the J&J vaccine did not outweigh its risks given that the country had the pandemic “under control” and had decent supplies of other jabs. Deputy director-general Helene Probst said that Denmark would in the coming weeks be mostly vaccinating “younger and healthy people” and that the risk of causing severe blood clots weighed heavier than what it would lose from not using the jab to fight the spread of Covid. “In the midst of an epidemic, this has been a difficult decision to make, especially since we have also had to discontinue using the Covid-19 vaccine from AstraZeneca,” she added.